Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Conversation logo

Do you own an oximeter? If so, do you know how and when to use it? It could save your life.

COVID-19 has killed at least 60,000 people in the UK. Many who die have a sudden drop in their blood oxygen levels a day or two before their lungs fail. Unlike in many other chest diseases (asthma, for example), COVID-19 can cause a severe drop in blood oxygen level without any associated breathlessness.

Because of this, people with this “silent hypoxia” are unlikely to seek the urgent help they need, unless they regularly measure their blood oxygen level or their condition deteriorates. If they realise something is wrong, they may reach hospital just in time to receive oxygen therapy (and, if necessary, ventilation). Others are admitted too late to save – or die at home.

The blood oxygen level is one of the strongest predictors of death in COVID-19, and early oxygen improves survival. So it’s time to learn to measure yours and to know what to do if it’s low.

Read the full article on The Conversation website, co-written by Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.